SUBSTITUTED BICYCLIC COMPOUNDS AS BROMODOMAIN INHIBITORS
申请人:ZENITH EPIGENETICS LTD.
公开号:US20190055235A1
公开(公告)日:2019-02-21
The present disclosure relates to substituted bicyclic compounds, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy.